% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • stockwatcher888 stockwatcher888 May 28, 2013 11:43 AM Flag

    What a joke and pure LIE!

    Gale is going to move back down to its 52 week low. Base on what?

    NeuVax has excellent results in terms of safety and efficacy on Phase 1 & 2, it is moving forward on Phase 3 with collaboration with FDA in trial design.

    Gale has a "best in Class" pain management product: "Abstral" to be marketed by Q3 this year.

    Interim reports on NeuVax and FBP are expected to be very good.

    With these solid and strong values, Gale's share price will have one way to go: Up and Up!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.4497+0.0136(+3.12%)Aug 23 4:00 PMEDT